Jiang Pi

5.4k total citations · 2 hit papers
110 papers, 4.1k citations indexed

About

Jiang Pi is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Jiang Pi has authored 110 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 25 papers in Biomedical Engineering and 21 papers in Materials Chemistry. Recurrent topics in Jiang Pi's work include Nanoplatforms for cancer theranostics (16 papers), Tuberculosis Research and Epidemiology (13 papers) and Nanoparticle-Based Drug Delivery (11 papers). Jiang Pi is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Tuberculosis Research and Epidemiology (13 papers) and Nanoparticle-Based Drug Delivery (11 papers). Jiang Pi collaborates with scholars based in China, Macao and United States. Jiang Pi's co-authors include Jiye Cai, Jinhuan Jiang, Hua Jin, Fen Yang, Jun‐Fa Xu, Huaihong Cai, Peihui Yang, Colin E. Evans, Zheng W. Chen and Junai Zhang and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Analytical Chemistry.

In The Last Decade

Jiang Pi

104 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications

2018 918 citations Jinhuan Jiang, Jiang Pi et al. profile →
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis

2020 274 citations Jiang Pi, Jun‐Fa Xu et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiang Pi China	34	1.3k	1.1k	1.0k	643	501	110	4.1k
Zbyněk Heger Czechia	30	1.7k 1.3×	886 0.8×	1.1k 1.1×	545 0.8×	262 0.5×	183	4.2k
Jun‐O Jin South Korea	43	1.5k 1.2×	714 0.6×	1.0k 1.0×	512 0.8×	1.2k 2.4×	177	5.1k
Jolanta Saczko Poland	30	1.1k 0.8×	850 0.8×	2.0k 2.0×	342 0.5×	393 0.8×	181	4.8k
Majid S. Jabir Iraq	50	1.1k 0.9×	2.3k 2.0×	1.6k 1.6×	798 1.2×	498 1.0×	251	5.8k
Vijay Mishra India	37	1.5k 1.2×	681 0.6×	1.0k 1.0×	1.0k 1.6×	278 0.6×	164	4.9k
Srinivas Mutalik India	45	1.4k 1.1×	1.0k 0.9×	1.2k 1.2×	1.2k 1.8×	358 0.7×	276	6.4k
Jin‐Wook Yoo South Korea	40	1.6k 1.3×	700 0.6×	1.7k 1.6×	2.1k 3.3×	379 0.8×	134	6.1k
Mohammad Zaki Ahmad India	36	938 0.7×	499 0.4×	902 0.9×	877 1.4×	392 0.8×	136	3.7k
Bo Yu China	43	2.2k 1.8×	1.2k 1.1×	2.0k 2.0×	1.3k 2.0×	348 0.7×	136	6.3k
Abbas Pardakhty Iran	38	1.6k 1.2×	582 0.5×	611 0.6×	678 1.1×	192 0.4×	143	4.5k

Countries citing papers authored by Jiang Pi

Since Specialization

Citations

This map shows the geographic impact of Jiang Pi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Pi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Pi more than expected).

Fields of papers citing papers by Jiang Pi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Pi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Pi. The network helps show where Jiang Pi may publish in the future.

Co-authorship network of co-authors of Jiang Pi

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Pi. A scholar is included among the top collaborators of Jiang Pi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Pi. Jiang Pi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiajun, Xiaoying Jin, Jiali Cai, et al.. (2025). Advancing roles of nitric oxide in tuberculosis: Promising targets for novel anti-TB therapeutics. Microbiological Research. 300. 128292–128292.

Guo, X. H., Yichu Nie, Tingting He, et al.. (2025). Multimetallic intra-nanogap nanozyme-mediated lateral flow immunoassay for ultrasensitive and multimode detection of K. pneumonia in clinical samples. Chemical Engineering Journal. 520. 166410–166410.

Xiang, Menghua, Fen Yang, Peng Chen, et al.. (2025). Tumor microenvironment-responsive self-assembled nanomedicine for reversible covalent targeting of BCR-ABL kinase. Chinese Chemical Letters. 37(2). 111423–111423. 1 indexed citations

Pi, Jiang, Dongsheng Chen, Jiajun Wang, et al.. (2024). Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy. Pharmacological Research. 208. 107379–107379. 14 indexed citations

Fan, Shuhao, Jiajun Wang, Dongsheng Chen, et al.. (2024). Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticles. Materials Today Bio. 28. 101232–101232. 9 indexed citations

Liu, Yilin, Jiajun Wang, Jiayi Yang, et al.. (2024). Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy. Journal of Nanobiotechnology. 22(1). 608–608. 7 indexed citations

Shahzad, Asif, Muhammad Arfat Yameen, Wenjing Liu, et al.. (2024). Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics. Biomedicine & Pharmacotherapy. 180. 117465–117465. 7 indexed citations

Zhao, Yue, Xin Shen, Xingxing Chai, et al.. (2024). Oral delivery of pH-sensitive nanoparticles loaded Celastrol targeting the inflammatory colons to treat ulcerative colitis. Journal of Tissue Engineering. 15. 1788756196–1788756196. 7 indexed citations

Chen, Dong, Liping Hu, Hanlin Zhou, et al.. (2024). Dual‐Enhanced SERS Satellite Immuno‐Nanocomplex for Multiple PSA‐Mediated PHI Assay Toward Clinical Prostate Cancer Screening. Advanced Science. 12(5). e2411747–e2411747. 6 indexed citations

10.

Zhang, Li, Yan Wang, Jiang Pi, et al.. (2024). Iron, Copper, and Zinc Homeostasis in the Battle between Macrophage and Mycobacterium Tuberculosis. Current Medicinal Chemistry. 32(16). 3155–3168. 3 indexed citations

11.

Li, Chaowei, Jiajun Wang, Jun‐Fa Xu, Jiang Pi, & Biying Zheng. (2024). Roles of HIF-1α signaling in Mycobacterium tuberculosis infection: New targets for anti-TB therapeutics?. Biochemical and Biophysical Research Communications. 711. 149920–149920. 6 indexed citations

12.

Pi, Jiang, et al.. (2024). Gut microbiota: a crucial player in the combat against tuberculosis. Frontiers in Immunology. 15. 1442095–1442095. 2 indexed citations

13.

Jin, Hua, Yue Zhao, Xin Shen, et al.. (2024). Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury. Antioxidants. 13(3). 282–282. 10 indexed citations

14.

Liu, Yilin, et al.. (2023). Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?. Pharmaceutics. 15(8). 2096–2096. 8 indexed citations

15.

Huang, Xueqin, Qiuxia Chen, Chan Huang, et al.. (2023). Chiral Au nanostars for SERS sensing of enantiomers discrimination, multibacteria recognition and photothermal antibacterial application. Chemical Engineering Journal. 479. 147528–147528. 41 indexed citations

16.

Bai, Juan, Depeng Liu, Xian‐Wei Wang, et al.. (2022). Tegument protein UL21 of alpha-herpesvirus inhibits the innate immunity by triggering CGAS degradation through TOLLIP-mediated selective autophagy. Autophagy. 19(5). 1512–1532. 63 indexed citations

17.

Pi, Jiang, Zhiyi Zhang, Enzhuo Yang, et al.. (2022). Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection. Journal of Nanobiotechnology. 20(1). 36–36. 16 indexed citations

18.

Huang, Xueqin, Huaihong Cai, Haibo Zhou, et al.. (2020). Cobalt oxide nanoparticle-synergized protein degradation and phototherapy for enhanced anticancer therapeutics. Acta Biomaterialia. 121. 605–620. 57 indexed citations

19.

Jin, Hua, Jiang Pi, Yue Zhao, et al.. (2017). EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy. Nanoscale. 9(42). 16365–16374. 100 indexed citations

20.

Pi, Jiang, Baole Li, Haiyan Zhu, et al.. (2015). Investigation of quercetin‐induced HepG2 cell apoptosis‐associated cellular biophysical alterations by atomic force microscopy. Scanning. 38(2). 100–112. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact